Skip to main content

Total brachial artery reactivity and incident heart failure and heart failure subtypes: multi-ethnic study of atherosclerosis

Abstract

Endothelial dysfunction may be a phenotypic expression of heart failure (HF). Total brachial artery reactivity (TBAR) is a non-invasive measurement of endothelial function that has been associated with increased risk of cardiovascular outcomes. Limited information is currently available on the impact of TBAR on incident HF and its subtypes. The aim of this study was to investigate whether TBAR is associated with overall incident HF, and the two HF subtypes, HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) in a community-based study. The sample included 5499 participants (45–84 years of age) from the Multi-Ethnic Study of Atherosclerosis who were free of cardiovascular disease at baseline. Brachial artery was imaged via ultrasound after five minutes of cuff occlusion at the right forearm. TBAR was calculated as the difference between maximum and minimum brachial artery diameters following cuff release, divided by the minimum diameter multiplied by 100%. A dichotomous TBAR variable was created based on the median value (below or above 7.9%). Participants with EF ≤ 40% were considered HFrEF and those with EF ≥ 50% were considered HFpEF. Cox proportional hazards regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI). Over a mean follow-up period of 12.5 years, incident HF was diagnosed in 250 participants: 98 classified as HFrEF, 106 as HFpEF, and 46 with unknown or borderline EF (41–49%). Crude analysis revealed that those with TBAR below the median had a significantly greater risk of HF (HR 1.46; 95% CI 1.13–1.88, p < 0.01) and HFrEF (HR 1.61; 95% CI 1.07–2.43, p < 0.05). Following adjustment for known HF risk factors (e.g., age, sex, race, blood pressure), the strength of these relationships was attenuated. Borderline significant results were revealed in those with HFpEF (HR 1.43; 95% CI 0.97–2.12, p = 0.06). Kaplan–Meier curves suggest significantly lower risks of developing HF and HFrEF in those with TBAR above the median (log-rank p ≤ 0.05 for both). When examined as a continuous variable, with a cut point of 50% for EF, every 1-standard deviation (9.7%) increase in TBAR resulted in a 19 and 29% decrease in risk of HF (p < 0.05) and HFrEF (p = 0.05), respectively. Lower TBAR values were associated with higher rates of incident HF and HFrEF, suggesting a possible role of endothelial dysfunction in HF pathogenesis. The impact of other known HF risk factors may mediate this relationship, thus further research is warranted.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Heitzer T, Baldus S, Von Kodolitsch Y, Rudolph V, Meinertz T (2005) Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol 25(6):1174–1179

    Article  CAS  Google Scholar 

  2. Alem MM (2019) Endothelial dysfunction in chronic heart failure: assessment, findings, significance, and potential therapeutic targets. Int J Mol Sci 20(13):3198

    Article  CAS  Google Scholar 

  3. Roger VL (2013) Epidemiology of heart failure. Circ Res 113(6):646–659

    Article  CAS  Google Scholar 

  4. Giannitsi S, Mpougiaklh M, Bechlioulis A, Naka K (2019) Endothelial dysfunction and heart failure: a review of the existing bibliography with emphasis on flow mediated dilation. JRSM Cardiovasc Dis 8:2048004019843047

    PubMed  PubMed Central  Google Scholar 

  5. Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, Levin R, Evers T, Wang SV, Desai RJ (2020) Risk factors for heart failure with preserved or reduced ejection fraction among Medicare beneficiaries: applications of competing risks analysis and gradient boosted model. Clin Epidemiol 12:607–616

    Article  Google Scholar 

  6. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW (2020) Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 141(9):e139–e596

    Article  Google Scholar 

  7. Chong AY, Blann AD, Lip GYH (2003) Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM 96(4):253–267

    Article  Google Scholar 

  8. Ärnlöv J, Sang Y, Ballew SH, Vaidya D, Michos ED, Jacobs DR Jr, Lima J, Shlipak MG, Bertoni AG, Coresh J, Blaha M, Post WS, Matsushita K (2020) Endothelial dysfunction and the risk of heart failure in a community-based study: the multi-ethnic study of atherosclerosis. ESC Heart Fail 7(6):4231–4240

    Article  Google Scholar 

  9. Polak JF, Ouyang P, Vaidya D (2019) Total brachial artery reactivity and first time incident coronary heart disease events in a longitudinal cohort study: the multi-ethnic study of atherosclerosis. PLoS One 14(4):e0211726

    Article  CAS  Google Scholar 

  10. Bild DE, Bluemke DA, Burke GL, Detrano R, Roux AVD, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156(9):871–881

    Article  Google Scholar 

  11. MESA overview and protocol. [cited 2021 Jan]. Available from http://www.nesa-nhlbi.org/aboutMesaOverviewProtocol.aspx.

  12. MESA Coordinating Center. MESA manual of operations: field center and laboratory procedures. [cited 2021 Jan]. Available from http://www.mesanhlbi.org/publicDocs/MesaMop/MesaMop1-5-01.doc.

  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2020) Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285(19):2486–2497

    Google Scholar 

  14. SAS Institute Inc (2016) Base SAS® 9.4 procedures guide: statistical procedures, 6th edn. SAS Institute Inc., Cary

    Google Scholar 

  15. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120(6):502–509

    Article  Google Scholar 

  16. Ostrem JD, Dengel DR, Marlatt KL, Steinberger J (2015) Comparison of baseline brachial artery measurements and effect on peak flow-mediated dilation. Clin Physiol Funct Imaging 35(1):34–40

    Article  Google Scholar 

  17. Hashimoto M, Kozaki K, Eto M, Akishita M, Ako J, Iijima K, Kim S, Toba K, Yoshizumi M, Ouchi Y (2000) Association of coronary risk factors and endothelium-dependent flow-mediated dilatation of the brachial artery. Hypertens Res 23(3):233–238

    Article  CAS  Google Scholar 

  18. Widmer Lerman RJA (2014) Endothelial dysfunction and cardiovascular disease. Glob Cardiol Sci Pract 3:291–308

    Google Scholar 

  19. Bauersachs J, Widder JD (2008) Endothelial dysfunction in heart failure. Pharmacol Rep 60(1):119–126

    CAS  PubMed  Google Scholar 

  20. Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction. J Am Coll Cardiol 62(4):263–271

    Article  Google Scholar 

  21. Dunlay SM, Weston SA, Jacobsen SJ, Roger VL (2009) Risk factors for heart failure: a population-based case-control study. Am J Med 122(11):1023–1028

    Article  Google Scholar 

  22. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24(2):471–476

    Article  CAS  Google Scholar 

  23. Paniagua OA, Bryant MB, Panza JA (2001) Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103(13):1752–1758

    Article  CAS  Google Scholar 

  24. Hadi AR, Suwaidi JA (2007) Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3(6):853–876

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Avogaro A, Albiero M, Menegazzo L, De Kreutzenberg S, Fadini GP (2011) Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34(Suppl 2):S285–S290

    Article  Google Scholar 

  26. Tromp J, Lim SL, Tay WT, Teng TK, Chandramouli C, Ouwerkerk W, Wander GS, Sawhney JPS, Yap J, MacDonald MR, Ling LH, Sattar N, McMurray JJV, Richards AM, Anand I, Lam CSP (2019) Microvascular disease in patients with diabetes with heart failure and reduced ejection fraction versus preserved ejection fraction. Diabetes Care 42:1792–1799

    Article  Google Scholar 

  27. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G (2011) Flow-mediated dilation and cardiovascular event prediction. Does nitric oxide matter? Hypertension 57(3):363–369

    Article  CAS  Google Scholar 

  28. Eskurza I, Seals DR, DeSouza CA, Tanaka H (2001) Pharmacological vs. flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans. Am J Cardiol 88(9):1067–1069

    Article  CAS  Google Scholar 

  29. Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ, Goodfellow J (2001) Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 101(6):629–635

    Article  CAS  Google Scholar 

  30. Vogel RA, Corretti MC, Plotnick GD (2000) A comparison of brachial artery flow-mediated vasodilation using upper and lower arm arterial occlusion in subjects with and without coronary risk factors. Clin Cardiol 23(8):571–575

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Charry.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Charry, D., Xu, J., Tanaka, H. et al. Total brachial artery reactivity and incident heart failure and heart failure subtypes: multi-ethnic study of atherosclerosis. Heart Vessels 37, 411–418 (2022). https://doi.org/10.1007/s00380-021-01933-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-01933-9

Keywords

  • Endothelial dysfunction
  • Heart failure
  • HFrEF
  • HFpEF